Durvalumab _ Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden
- Luis Paz-Ares
- , Marina Chiara Garassino
- , Yuanbin Chen
- , Niels Reinmuth
- , Katsuyuki Hotta
- , Artem Poltoratskiy
- , Dmytro Trukhin
- , Maximilian J. Hochmair
- , Mustafa Özgüroǧlu
- , Jun Ho Ji
- , Galina Statsenko
- , Nikolay Conev
- , Igor Bondarenko
- , Libor Havel
- , György Losonczy
- , Mingchao Xie
- , Zhongwu Lai
- , Nadia Godin-Heymann
- , Helen Mann
- , Haiyi Jiang
- Complutense University
- IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
- The University of Chicago
- Cancer and Hematology Centers of Western Michigan
- Member of the German Center for Lung Research (DZL)
- Okayama University
- Russian Ministry of Health
- Odessa Regional Oncological Dispensary
- Klinik Floridsdorf
- Istanbul University - Cerrahpaşa
- Samsung Changwon Hospital
- Omsk Regional Cancer Center
- Clinic of Medical Oncology
- Zaporizhia Medical Academy of Post-Gradate Education Ministry of Health of Ukraine
- Charles University
- Semmelweis University
- AstraZeneca
- Astra- Zeneca
- University of California at Los Angeles
Research output: Contribution to journal › Article › peer-review
55
Link opens in a new tab
Scopus
citations